SA Pharmaceutical Journal - Volume 81, Issue 6, 2014
Volume 81, Issue 6, 2014
Author Lorraine OsmanSource: SA Pharmaceutical Journal 81 (2014)More Less
I read Jan du Toit's article with interest. Having served on the Committee for Preliminary Inquiry (CPI) for 10 years, and chaired some Committees of Formal Inquiry (CFI), I obviously developed an interest in disciplinary matters. When I was first asked to serve on the CPI, my immediate reaction was: "No. I don't want to get involved with that. I don't want to prosecute or persecute pharmacists!"
Author Johann KrugerSource: SA Pharmaceutical Journal 81 (2014)More Less
Knowledge is power (to quote Francis Bacon), and with great power (to quote Stan Lee) comes great responsibility.
As pharmacists, we take great pride in the scientific basis of our training, and we rely on that to reduce the misery that is inflicted on mankind by disease. On a daily basis, we use our training to treat patients' symptoms, clear up infections or generally improve their quality of life. Pharmacists no longer prepare their own lotions and potions. Over time, ready-made medication packages have resulted, researched and manufactured by our colleagues in industry. However, that would not exonerate us, as part of a healthcare team, if something went wrong while treating a patient.
Source: SA Pharmaceutical Journal 81, pp 11 –18 (2014)More Less
Gout is a common crystal-induced inflammatory arthritis, the prevalence and clinical complexity of which is increasing in the face of a growing aged population with multiple co-morbidities. Recent epidemiological studies emphasise that lifestyle factors strongly influence the development of hyperuricaemia and gout. Moreover, there is growing evidence that gout is an independent risk factor for cardiovascular disease. Acute attacks of gout are extremely painful and disabling, and if repeated attacks go untreated, chronic deforming arthritis ensues. Early diagnosis and appropriate therapy is essential to reduce long-term disability. The identification of monosodium urate crystals via synovial fluid analysis is the gold standard in gout diagnosis. Non-steroidal anti-inflammatory drugs and oral or intra-articular corticosteroids remain central to the treatment of acute attacks. Prophylactic colchicine use during the intercritical period reduces gout flares, a common complication on initiation of urate-lowering therapy. Allopurinol is the treatment of choice when urate-lowering therapy is indicated. Gout management is suboptimal in many patients because of non-adherence to treatment and the underutilisation of available treatments. When treating to target, a serum uric acid level < 0.35 mmol/l prevents crystal deposition in joints and soft tissues, thereby preventing acute attacks and ongoing inflammation, as well as decreasing the size and number of tophi. Treatment strategies should include attention to cardiovascular risk. The family practitioner is paramount to gout management, which should be individualised. Emphasis should be placed on ongoing education and prevention.
Source: SA Pharmaceutical Journal 81, pp 19 –26 (2014)More Less
The common cold is a viral infection that requires symptomatic treatment. It is usually self-limiting. Influenza is often referred to as the flu. There are several differences between the common cold and the flu, including the onset of the condition as influenza is typically more acute in onset and more debilitating. Treatment of both these conditions requires a symptomatic approach that should be evidence-based, including herbal remedies, over-the-counter medicines, antiviral agents and analgesics for pain and fever. This will be discussed in more detail in the ensuing section.
Author Gail MkeleSource: SA Pharmaceutical Journal 81, pp 27 –29 (2014)More Less
There has been much controversy regarding the use of hormone replacement therapy (HRT), also known as menopausal hormone therapy, in the past decade. Evidence from clinical trials challenged previously accepted recommendations for HRT in menopausal women, especially with regard to aspects of safety and disease prevention. This led to much confusion for clinicians, as well as patients, with many symptomatic menopausal women unnecessarily being denied HRT. Different reviews of published clinical data have necessitated that menopausal societies around the world reach a global consensus on the core recommendations regarding HRT. Consensus has now been reached and a global consensus statement on menopausal hormone therapy was published in 2013 by the International Menopause Society. This article will provide a summary of the key highlights from the consensus statement.
Author Lisa SelwoodSource: SA Pharmaceutical Journal 81, pp 30 –32 (2014)More Less
Obsessive compulsive disorder (OCD) is a frequent, chronic, costly and disabling disorder characterised by recurrent intrusive ideas, images, ruminations, impulses and thoughts (obsessions), which increase anxiety and repetitive patterns of behaviour (compulsions), in an attempt to decrease anxiety. It is one of the most disabling psychiatric conditions, and has a negative impact on the quality of life of both patients and those close to them. When correctly recognised and diagnosed, it can be successfully treated. The World Health Organization ranks OCD as one of the 10 most disabling conditions in terms of lost income and decreased quality of life.
Understanding the disciplinary process of the South African Pharmacy Council : pharmaceutical practitionerAuthor Jan Du ToitSource: SA Pharmaceutical Journal 81, pp 33 –34 (2014)More Less
In terms of Section 39 of the Pharmacy Act 53/1974 ("the Act"), among others, the South African Pharmacy Council (SAPC) may "enquire into any matter which is brought to the attention of the Council, or any complaint, charge or allegation of improper or disgraceful conduct against any person registered in terms of this Act". Although the SAPC is fully empowered in law to enquire into any matter relating to, for example, alleged unprofessional conduct by a person registered with it, such an enquiry must follow a prescribed process to ensure that the best interests of both the registered person and the complainant are served.
Author Stephan MollerSource: SA Pharmaceutical Journal 81 (2014)More Less
Any pharmacist who is even vaguely interested in pharmacy trends or what the immediate future of pharmacy will look like, would agree that our traditional way of dispensing medication is becoming increasingly inadequate, and that a growing need for therapy management is expected from our clients. Some pharmacists are already providing wider counselling services that extend beyond the traditional notion of how and when to take medication, and potential associated side-effects. Additionally, these pharmacists are increasingly providing a wider range of services, and are being reimbursed for them. If I could simplify this trend, it would be to move away from a dispensing-centric function towards a services-centric function.
Source: SA Pharmaceutical Journal 81, pp 36 –37 (2014)More Less
Arrangements are well underway for the 2015 South African Association of Hospital and Institutional Pharmacists (SAAHIP) Conference, which will take place from 12-15 March, 2015. The conference will be hosted jointly by the KwaZulu-Natal Inland and Coastal Branches, and will again be held at the spectacular Champagne Sports Resort in the Drakensberg.
Author Janine McEwanSource: SA Pharmaceutical Journal 81, pp 39 –40 (2014)More Less
Technology is entrenched in practically every aspect of our daily lives, so it makes sense that the health industry is embracing the use of technology to improve patient safety and minimise human error. A significant number of adverse drug events in South African hospitals every year can be attributed to human error, which is why the adoption of barcode technology has become so critical.
Report to the AGM of the Academy of Pharmaceutical Sciences of the Pharmaceutical Society of South Africa : cum laudeAuthor Shirley-Anne BoschmansSource: SA Pharmaceutical Journal 81, pp 41 –42 (2014)More Less
Source: SA Pharmaceutical Journal 81 (2014)More Less
This "nibble" is slightly different from past columns. Usually, in this column, you are invited to share your opinion, experience or wisdom with other readers of the SAPJ. However, this month, we publish a speech that was delivered by Prof Anton Dreyer 19 years ago on 28 November 1997. The question is: "Is it still relevant today?" Anton's response is: "The dream in my heart remains as strong as ever".